María Antonia
Fortuño Cebamanos
Profesional Investigadora
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Médica Aplicada (9)
2021
-
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Blood Cancer Journal, Vol. 11, Núm. 12
2017
-
Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods
Journal of Proteomics, Vol. 150, pp. 109-120
2014
-
Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 12, pp. 2448-2456
2011
-
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone
American Journal of Physiology - Heart and Circulatory Physiology, Vol. 301, Núm. 6, pp. 2372-2382
2010
-
Aldosterone and the cardiovascular system: A dangerous association
Hormone Molecular Biology and Clinical Investigation, Vol. 4, Núm. 2, pp. 539-548
2008
-
Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes
Endocrinology, Vol. 149, Núm. 10, pp. 4970-4978
-
Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome
American Journal of Physiology - Endocrinology and Metabolism, Vol. 294, Núm. 1
2006
-
Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats
Journal of Molecular and Cellular Cardiology, Vol. 41, Núm. 5, pp. 902-913
2003
-
Clinical implications of apoptosis in hypertensive heart disease
American Journal of Physiology - Heart and Circulatory Physiology